Table 3. Univariate and multivariate analyses of OS rates in the 169 stage 3 and 4 patients by Cox regression model.
Variable | Univariate analysis | Multivariate analysis | |||||
---|---|---|---|---|---|---|---|
P | HR | 95% CI | P | HR | 95% CI | ||
Age | 12 months | 1 | 1 | ||||
12–60 months | .022 | 2.729 | 1.159–6.426 | .544 | .674 | .188–2.410 | |
≥60 months | .039 | 2.594 | 1.049–6.415 | .599 | .691 | .174–2.743 | |
Sex (Female vs. male) | .709 | .914 | .570–1.466 | .968 | 1.010 | .616–1.657 | |
Site | Adrenal gland | 1 | |||||
Mediastinum | .130 | .524 | .227–1.210 | ||||
Others | .868 | .918 | .334–2.524 | ||||
INSS stage (4 vs. 3) | .002 | 2.451 | 1.408-4.266 | .262 | 1.398 | .778-2.512 | |
Risk group(High-risk vs. intermediate-risk) | .000 | 10.005 | 3.140–31.873 | .007 | 7.829 | 1.752–34.983 | |
Grade of differentiation | Undifferentiated subtye | 1 | 1 | ||||
Poorly differentiated subtype | .005 | .519 | .330–.817 | .794 | .931 | .546–1.587 | |
Differentiating subtype | .035 | .118 | .016–.863 | .807 | .735 | .062–8.695 | |
FH/UH (FH vs UH) | .003 | .313 | .143–.682 | .874 | 1.110 | .308–3.996 | |
MYCN status (Unamplificaction vs. amplification) | .000 | .247 | .154–.394 | .001 | .357 | .196-.651 | |
ASCT (No vs. yes) | .193 | 1.557 | .799–3.032 | ||||
Radiation (No vs. yes) | .105 | .678 | .423–1.085 | ||||
Surgical methods(STR vs. GTR) | .011 | 1.794 | 1.143–2.817 | .047 | 1.590 | 1.006–2.513 |
Notes.
Abbreviations
- HR
- hazard ratio
- CI
- confidence interval
- FH
- favorable histology
- UH
- unfavorable histology
- ASCT
- autologous stem cell transplantation
- STR
- subtotal resection
- GTR
- gross total resection